These results suggest that in VAT of patients with extreme obesity and with T2DM associated with high VAT-E2F1 expression, up-regulation of E2F1 associates with changes in miRNA expression distinct from those known in malignant disease contexts. The gene discussed is E2F1; the disease is type 2 diabetes mellitus.